(S1 (S (S (NP (NN Kaiso)) (VP (VBZ is) (NP (NP (DT a) (JJ bimodal) (NN modulator)) (PP (IN for) (NP (NN Wnt/beta-catenin) (NN signaling)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN Wnt) (NN family)) (PP (IN of) (NP (JJ secreted) (NNS ligands)))) (VP (VBZ plays) (NP (JJ critical) (NNS roles)) (PP (IN during) (NP (JJ embryonic) (NP (NN development)) (CC and) (NP (NN tumorigenesis)))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN Kaiso)) (, ,) (NP (DT a) (JJ dual) (JJ specific) (JJ DNA-binding) (NN protein)) (, ,)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (JJ bimodal) (NN regulator)) (PP (IN of) (NP (JJ canonical) (NN Wnt) (NN signaling)))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Loss-of-function) (NN analysis)) (PP (IN of) (NP (NN Kaiso)))) (VP (VBD abrogated) (NP (NP (JJ Wnt-mediated) (NN reporter) (NN activity)) (CC and) (NP (NN axis) (NN duplication))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN gain-of-function) (NN analysis)) (PP (IN of) (NP (NN Kaiso)))) (ADVP (RB dose-dependently)) (VP (VBD resulted) (PP (IN in) (NP (ADJP (ADJP (JJ synergistic)) (CC and) (ADJP (JJ suppressive))) (NNS effects)))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS analyses)) (ADVP (RB further)) (VP (VBP suggest) (NP (NN Kaiso)) (VP (MD can) (VP (VB regulate) (NP (NP (NN TCF/LEF1-activity)) (PP (IN for) (NP (DT these) (NNS effects)))) (PP (IN via) (S (VP (VBG modulating) (NP (NP (NN HDAC1)) (CC and) (NP (NN beta-catenin-complex) (NN formation)))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS studies)) (ADVP (RB together)) (VP (VBP provide) (NP (NP (NNS insights)) (PP (IN into) (SBAR (WHADVP (WRB why)) (S (NP (NN Kaiso) (JJ null) (NNS mice)) (VP (VBP display) (NP (NP (NN resistance)) (PP (TO to) (NP (JJ intestinal) (NNS tumors)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN crossed) (PP (IN onto) (NP (DT an) (JJ Apc-LRB-Min/+-RRB-) (NN background))))))))))))) (. .)))
